|
*停權中*
|
引用:
|
作者終極密碼
某間就是一間垃圾生技公司
股票炒到快1000億新台幣市值
還有一點沒有通過三期不準用台灣人民的性命來測試你家疫苗.
台積電和郭董加油1000萬劑BNT疫苗就是救500萬台灣人命.
|
BNT 在美國做的臨床實驗1/2/3期也還沒做完，
“Primary Completion Date :November 2, 2021”
要不然你等到預計的今年11月2日結束再說？
“Estimated Study Completion Date :May 2, 2023”
預計研究結束是2023/5/2
全部做完比較保險吧？！
萬一有那個疫苗打完兩年後才出現大量嚴重症狀怎麼辦？
你不要有雙重標準啊！
市面上看那一家三期臨床實驗完全做完你再打吧？！
引用:
https://clinicaltrials.gov/ct2/show/NCT04368728
Study Type :
Interventional (Clinical Trial)
Estimated Enrollment :
43998 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Prevention
Official Title:
A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS
Actual Study Start Date :
April 29, 2020
Estimated Primary Completion Date :
November 2, 2021
Estimated Study Completion Date :
May 2, 2023
|
|